Morisset Valerie 4
4 · Eliem Therapeutics, Inc. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
Morisset Valerie
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2024-07-01$0.00/sh+7,649$2→ 512,956 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-07-01−7,649→ 10,198 totalExercise: $0.00Exp: 2031-02-25→ Common Stock (7,649 underlying) - Sale
Common Stock
2024-07-03$6.76/sh−50,000$338,000→ 462,956 total
Footnotes (1)
- [F1]The shares subject to this option shall vest at a rate of 12/48ths of the total number of shares on the one-year anniversary of February 26, 2021 (the "February 2021 Vesting Commencement Date") and 1/48thof the total number of shares each monthly anniversary of the February 2021 Vesting Commencement Date thereafter (or if there is no corresponding day, on the last day of the month) for so long as the Reporting Person remains an officer, director, employee, consultant and/or advisor of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the February 2021Vesting Commencement Date.